Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions.

Hermann R, von Richter O.

Planta Med. 2012 Sep;78(13):1458-77. doi: 10.1055/s-0032-1315117. Epub 2012 Aug 1. Review.

2.

Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.

Goey AK, Mooiman KD, Beijnen JH, Schellens JH, Meijerman I.

Cancer Treat Rev. 2013 Nov;39(7):773-83. doi: 10.1016/j.ctrv.2012.12.008. Epub 2013 Feb 8. Review.

PMID:
23394826
3.
4.

Drug interactions with phytotherapeutics in oncology.

Haefeli WE, Carls A.

Expert Opin Drug Metab Toxicol. 2014 Mar;10(3):359-77. doi: 10.1517/17425255.2014.873786. Epub 2014 Jan 6. Review.

PMID:
24387348
5.

Clinical herbal interactions with conventional drugs: from molecules to maladies.

Chen XW, Serag ES, Sneed KB, Liang J, Chew H, Pan SY, Zhou SF.

Curr Med Chem. 2011;18(31):4836-50. Review.

PMID:
21919844
6.
7.

Interactions of herbs with cytochrome P450.

Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW.

Drug Metab Rev. 2003 Feb;35(1):35-98. Review.

PMID:
12635815
8.

Evaluation of metabolism-mediated herb-drug interactions.

Na DH, Ji HY, Park EJ, Kim MS, Liu KH, Lee HS.

Arch Pharm Res. 2011 Nov;34(11):1829-42. doi: 10.1007/s12272-011-1105-0. Epub 2011 Dec 3. Review.

PMID:
22139684
9.

A critical evaluation of drug interactions with Echinacea spp.

Freeman C, Spelman K.

Mol Nutr Food Res. 2008 Jul;52(7):789-98. doi: 10.1002/mnfr.200700113. Review.

PMID:
18618481
10.

Phenotyping studies to assess the effects of phytopharmaceuticals on in vivo activity of main human cytochrome p450 enzymes.

Zadoyan G, Fuhr U.

Planta Med. 2012 Sep;78(13):1428-57. doi: 10.1055/s-0031-1298536. Epub 2012 May 15. Review.

11.

Cytochrome P450 enzyme mediated herbal drug interactions (Part 1).

Wanwimolruk S, Prachayasittikul V.

EXCLI J. 2014 Apr 2;13:347-91. eCollection 2014. Review.

12.

Drug interactions with herbal medicines.

Shi S, Klotz U.

Clin Pharmacokinet. 2012 Feb 1;51(2):77-104. doi: 10.2165/11597910-000000000-00000. Review.

PMID:
22257149
13.
14.

[Pharmacokinetic drug interactions by herbal drugs: Critical evaluation and clinical relevance].

Unger M.

Wien Med Wochenschr. 2010 Dec;160(21-22):571-7. doi: 10.1007/s10354-010-0848-4. Review. German.

PMID:
21170698
15.

Possible drug-metabolism interactions of medicinal herbs with antiretroviral agents.

van den Bout-van den Beukel CJ, Koopmans PP, van der Ven AJ, De Smet PA, Burger DM.

Drug Metab Rev. 2006;38(3):477-514. Review.

PMID:
16877262
16.

Herb-drug interactions: a literature review.

Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, Duan W, Koh HL, Zhou S.

Drugs. 2005;65(9):1239-82. Review.

PMID:
15916450
17.

MDR- and CYP3A4-mediated drug-herbal interactions.

Pal D, Mitra AK.

Life Sci. 2006 Mar 27;78(18):2131-45. Epub 2006 Jan 25. Review.

PMID:
16442130
18.

Pharmacokinetic herb-drug interactions (part 2): drug interactions involving popular botanical dietary supplements and their clinical relevance.

Gurley BJ, Fifer EK, Gardner Z.

Planta Med. 2012 Sep;78(13):1490-514. doi: 10.1055/s-0031-1298331. Epub 2012 May 7. Review.

19.

Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans.

Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CY.

Clin Pharmacol Ther. 2002 Sep;72(3):276-87.

PMID:
12235448
20.

An ex vivo approach to botanical-drug interactions: a proof of concept study.

Wang X, Zhu HJ, Munoz J, Gurley BJ, Markowitz JS.

J Ethnopharmacol. 2015 Apr 2;163:149-56. doi: 10.1016/j.jep.2015.01.021. Epub 2015 Jan 24.

Supplemental Content

Support Center